AptarGroup Q3 revenue $825M (+9% YoY); adjusted EPS $0.94 vs $1.01; guides Q4 $0.88-$0.96

APTARGROUP, INC.

2021-Q3 EPS reported $2.75 revenue$2,413,228,000

Reported sales $825M, +9% YoY; core sales +8%; Pharma core -2%, Beauty+Home +10%, Food+Beverage +28%.
Reported EPS $0.70 (includes $0.12 restructuring, $0.10 unrealized loss on PureCycle investment, $0.02 acquisition costs); adjusted EPS $0.94.
Adjusted EBITDA $154M; net income $47M.
Completed acquisitions: 80% of Weihai Hengyu Medical Products and majority stake in Voluntis.
Q4 2021 adjusted EPS guidance $0.88-$0.96; quarterly dividend $0.38/share payable Nov 17, 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.